Songjiang Ma - Aug 14, 2024 Form 4 Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Role
President, Director
Signature
/s/ Ruoyu Chen, as attorney-in-fact for Songjiang Ma
Stock symbol
GYRE
Transactions as of
Aug 14, 2024
Transactions value $
$0
Form type
4
Date filed
8/16/2024, 09:01 PM
Previous filing
Nov 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GYRE Stock Option (Right to Buy) Award $0 +26K $0.00 26K Aug 14, 2024 Common Stock 26K $9.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 26,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through August 14, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date.